We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
FORMA Therapeutics has successfully completed a critical objective under its strategic collaboration agreement with Celgene, triggering an undisclosed payment from Celgene
FORMA Therapeutics, a clinical-stage and fully integrated discovery and development company, has announced the achievement of a clinical development milestone in their alliance with Boehringer Ingelheim (BI).